1-3 of 3
Bridget McGowan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aggressive Electrolytes Replacement in Multiple Myeloma (MM) Patients Receiving Arsenic Trioxide (ATO) Containing Regimens Alleviates the Need for Frequent Electrocardiogram (ECG) Monitoring.

Toni K. Choueiri, MD, Esteban Walker, PhD, Rachid C. Baz, MD, Rony M. Abou-Jawde, MD, Snehal G. Thakkar, MD, Bridget McGowan, Megan Kelly, Steven Andresen, MD, Mohamad Hussein, MD
Journal: Blood
Blood (2005) 106 (11): 5155.
https://doi.org/10.1182/blood.V106.11.5155.5155
Published: 2005
Journal Articles

Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) Results in a High Response Rate in Patients with Refractory Multiple Myeloma (RMM).

Rachid Baz, MD, Toni K. Choueiri, MD, Rony Abou Jawde, MD, Bridget McGowan, Yvette Ellis, Catherine Brand, Mohamad A. Hussein, MD
Journal: Blood
Blood (2005) 106 (11): 2559.
https://doi.org/10.1182/blood.V106.11.2559.2559
Published: 2005
Journal Articles

A Phase II Trial of Doxil, Vincristine and Reduced Schedule Dexamethasone (DVd) for Patients with Relapsed or Refractory Multiple Myeloma.

Paul Masci, D.O., Mary A. Karam, R.N., Luba Platt, B.S., Steven Andresen, D.O, Alan Lichtin, M.D., Bridget McGowan, B.S., Mohamad Hussein, M.D.
Journal: Blood
Blood (2004) 104 (11): 2415.
https://doi.org/10.1182/blood.V104.11.2415.2415
Published: 2004